Banque Internationale à Luxembourg S.A. Stock

Certificat

AATBIL

CH1143781818

Market Closed - Swiss Exchange 11:20:00 2024-06-27 EDT
36.25 EUR -5.25% Intraday chart for Banque Internationale à Luxembourg S.A.
Current month-12.65%
1 month-17.01%
Date Price Change
24-06-27 36.25 -5.25%
24-06-26 38.26 -2.07%
24-06-25 39.07 +1.38%
24-06-24 38.54 +1.05%
24-06-20 38.14 +1.33%

Delayed Quote Swiss Exchange

Last update June 27, 2024 at 11:20 am

More quotes

Static data

Product typeOther Certificates
Buy / SellCALL
Underlying PFIZER, INC.
Issuer Banque Internationale à Luxembourg S.A.
AATBIL
ISINCH1143781818
Date issued 2021-12-16
Maturity 2026-12-16 (901 Days)
Parity 0.06 : 1
Emission price 100
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 86.88
Lowest since issue 25.79
Spread 5
Spread %1.37%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
27.98 USD
Average target price
31.92 USD
Spread / Average Target
+14.07%
Consensus
  1. Stock Market
  2. Certificates
  3. AATBIL Certificat